Nuvation Bio NUVB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$145.99M+75.9% | -$204.63M+64.0% | -$217.48M+59.1% | -$202.9M+60.3% | -$606.38M-781% | ||
| $1.97M+110% | $1.74M+155% | $1.42M+173% | $1.05M+154% | $935K+317% | ||
| $37.07M+5.7% | $35.89M+11.2% | $38.1M+47.6% | $37.55M+58.0% | $35.09M+78.0% | ||
| -$125.73M+20.1% | -$173.43M-33.0% | -$190M-91.6% | -$168.19M-99.7% | -$157.34M-144% | ||
| $7.98M+17,624% | $8M— | $8M+61,438% | $226K+265% | $45K-46.4% | ||
| —— | —— | —— | $189.95M+190% | $169.34M+147% | ||
| $202.03M— | $202.54M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$133.71M+15.0% | -$181.43M-39.1% | -$198M-99.7% | -$168.42M-99.9% | -$157.38M-144% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvation Bio generate?
- Nuvation Bio (NUVB) generated -$125.7M in operating cash flow over the trailing twelve months.
- What is Nuvation Bio's free cash flow?
- After $8.0M of capital expenditures, Nuvation Bio's free cash flow was -$133.7M over the trailing twelve months, up 15.0% year over year.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
